Dunhill Financial LLC Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Dunhill Financial LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 46.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 612 shares of the healthcare conglomerate’s stock after purchasing an additional 194 shares during the quarter. Dunhill Financial LLC’s holdings in UnitedHealth Group were worth $310,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Eagle Global Advisors LLC raised its stake in shares of UnitedHealth Group by 3.5% during the fourth quarter. Eagle Global Advisors LLC now owns 37,203 shares of the healthcare conglomerate’s stock valued at $18,820,000 after purchasing an additional 1,245 shares during the period. EHP Funds Inc. increased its stake in UnitedHealth Group by 77.8% during the 4th quarter. EHP Funds Inc. now owns 1,600 shares of the healthcare conglomerate’s stock worth $809,000 after buying an additional 700 shares during the period. Colonial Trust Co SC boosted its position in UnitedHealth Group by 0.6% in the 4th quarter. Colonial Trust Co SC now owns 16,326 shares of the healthcare conglomerate’s stock valued at $8,258,000 after buying an additional 100 shares during the last quarter. CoreCap Advisors LLC increased its position in shares of UnitedHealth Group by 127.5% during the fourth quarter. CoreCap Advisors LLC now owns 3,553 shares of the healthcare conglomerate’s stock worth $1,797,000 after acquiring an additional 1,991 shares during the last quarter. Finally, Capital Advantage Inc. purchased a new position in UnitedHealth Group in the fourth quarter valued at about $237,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 2.4 %

Shares of UNH stock opened at $395.21 on Wednesday. The firm has a market capitalization of $359.73 billion, a PE ratio of 25.50, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $393.11 and a 1 year high of $630.73. The stock has a fifty day moving average of $493.20 and a two-hundred day moving average of $526.12.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm posted $6.91 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.13%. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

Analysts Set New Price Targets

Several research firms have recently commented on UNH. HSBC reiterated a “hold” rating and set a $490.00 target price on shares of UnitedHealth Group in a research note on Tuesday, April 22nd. Raymond James reissued a “strong-buy” rating and issued a $540.00 target price (down previously from $635.00) on shares of UnitedHealth Group in a research report on Monday, April 21st. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Barclays cut their price objective on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a research note on Monday, April 21st. Finally, Mizuho boosted their price target on UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Four analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $596.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.